Novartis will continue to do bolt-on deals and its capital allocation priorities remain unchanged, CEO Vasant Narasimhan said ...

Novartis recently announced it has reached an agreement with the U.S. government that aims to lower the price of innovative ...

TrumpRx is supposed to launch in early 2026. Here's what we know about how buying medicine through the site to get discounts on prescription drugs will work ...

Beginning this year, Medicare's new negotiated drug prices could cut prescription costs in half for millions of seniors, a ...

In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the maximum price drug manufacturers can charge Medicare plans for 10 popular ...

In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the ...

Savings for Part D and Advantage enrollees depend largely on which plan they’re enrolled in, as not all plans are the same.

There’s good news in 2026 for seniors enrolled in Medicare Part D who rely on the priciest prescription drugs: 10 high-cost ...

In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the ...

Objectives To review the metrics and findings of studies evaluating effects of drug decriminalisation or legal regulation on drug availability, use or related health and social harms globally. Design ...

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.